GlaxoSmithKline Picks Goldman, Sachs & Co. Partner for Next CFO

New York Times -- GlaxoSmithKline, the British pharmaceutical giant, said on Wednesday that Simon Dingemans, head of the European M.&A. business at Goldman Sachs, would become its new chief financial officer.